Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic field-guided accumulation is a drug delivery method wherein magnetic nanoparticles, carriers, or vesicles loaded with therapeutic agents are administered into the body and then concentrated at a precise target site by applying an external magnetic field[1][3][5]. This enables enhanced local accumulation, improved specificity (especially for cancer and thrombosis), minimized side effects, and controlled release (sometimes by triggering thermal responses with dynamic magnetic fields)[1][5][6][7]. Magnetic field-guided delivery is a rapidly developing technology for targeted therapy, diagnosis, and controlled release, but it is not a molecule, receptor, or protein; rather, it is an enabling technology[1][3][4].
Physical attraction and accumulation of magnetic carriers/drugs at target site via external magnetic field Triggering drug release by inducing hyperthermia with alternating magnetic fields
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic field-guided accumulation.